We are live on ! Find out more
SRC

Shufro Rose & Co Portfolio holdings

AUM $1.47B
1-Year Est. Return 19.38%
This Fund
S&P 500
This Quarter Est. Return
+0.38%
1 Year Est. Return
+19.38%
3 Year Est. Return
+47.49%
5 Year Est. Return
+55.37%
10 Year Est. Return
+200.77%
AUM
$1.27B
AUM Growth
-$27.4M
Cap. Flow
-$19.9M
Cap. Flow %
-1.57%
Top 10 Hldgs %
41.69%
Holding
322
New
24
Increased
70
Reduced
105
Closed
8

Sector Composition

Rank Sector Weight
1 Technology 18.51%
2 Financials 7.86%
3 Healthcare 7.77%
4 Consumer Discretionary 6.07%
5 Industrials 3.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVDV icon
76
Avantis International Small Cap Value ETF
AVDV
$19B
$1.96M 0.15%
28,049
-155
-0.5% -$10.5K
VSS icon
77
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.2B
$1.92M 0.15%
16,626
-1,508
-8% -$175K
UNP icon
78
Union Pacific
UNP
$174B
$1.89M 0.15%
8,007
+5,028
+169% +$1.21M
NYT icon
79
New York Times
NYT
$12.1B
$1.84M 0.15%
37,165
JJSF icon
80
J&J Snack Foods
JJSF
$1.43B
$1.84M 0.15%
13,941
YUM icon
81
Yum! Brands
YUM
$41.8B
$1.8M 0.14%
11,468
GOOGL icon
82
Alphabet (Google) Class A
GOOGL
$4.36T
$1.77M 0.14%
11,475
-213
-2% -$38.6K
GOOG icon
83
Alphabet (Google) Class C
GOOG
$4.36T
$1.77M 0.14%
11,343
-500
-4% -$91.6K
USMV icon
84
iShares MSCI USA Min Vol Factor ETF
USMV
$23.5B
$1.74M 0.14%
18,584
-796
-4% -$73.3K
SHEL icon
85
Shell
SHEL
$254B
$1.72M 0.14%
23,514
+3,064
+15% +$206K
J icon
86
Jacobs Solutions
J
$15.9B
$1.68M 0.13%
14,054
-505
-3% -$65K
ALB.PRA icon
87
Albemarle Corp Depositary Shares
ALB.PRA
$2.29B
$1.68M 0.13%
47,000
+29,900
+175% +$1.18M
REGN icon
88
Regeneron Pharmaceuticals
REGN
$78.5B
$1.67M 0.13%
2,639
-47
-2% -$32.3K
UMH
89
UMH Properties
UMH
$1.29B
$1.61M 0.13%
86,050
-800
-0.9% -$14.6K
REGN icon
90
PUT
Regeneron Pharmaceuticals
REGN
$78.5B
0
EUSA icon
91
iShares MSCI USA Equal Weighted ETF
EUSA
$1.81B
$1.57M 0.12%
16,730
+560
+3% +$54.2K
AL
92
DELISTED
Air Lease Corp
AL
$1.56M 0.12%
32,350
COP icon
93
ConocoPhillips
COP
$147B
$1.56M 0.12%
14,811
+1,195
+9% +$119K
PPLI
94
People Inc
PPLI
$3.09B
$1.55M 0.12%
41,019
+5,119
+14% +$187K
NEAR icon
95
iShares Short Maturity Bond ETF
NEAR
$4.83B
$1.53M 0.12%
29,981
+2,242
+8% +$114K
IQLT icon
96
iShares MSCI Intl Quality Factor ETF
IQLT
$13.8B
$1.51M 0.12%
37,940
-3,381
-8% -$133K
MRK icon
97
Merck
MRK
$322B
$1.5M 0.12%
16,668
-908
-5% -$84.8K
PFF icon
98
iShares Preferred and Income Securities ETF
PFF
$13.3B
$1.5M 0.12%
48,685
-2,100
-4% -$66.2K
EFAV icon
99
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.34B
$1.44M 0.11%
18,493
-283
-2% -$21.1K
EQIX icon
100
Equinix
EQIX
$101B
$1.43M 0.11%
1,757
-50
-3% -$44.9K

Similar funds

Shufro Rose & Co's Q1 2025 Portfolio in Review

As of Q1 2025, Shufro Rose & Co held 322 positions worth $1.27B, down 2.1% from $1.29B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Shufro Rose & Co's Q1 2025 filing shows 24 new, 70 increased, 105 reduced and 8 closed positions. Its largest new stake was iShares iBonds Dec 2029 Term Corporate ETF: 3,590,158 shares worth $83M. The largest sale was iShares iBonds Dec 2027 Term Corporate ETF, an estimated $81.7M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.

  • Shufro Rose & Co's largest Q1 2025 buy was iShares iBonds Dec 2029 Term Corporate ETF: 3,590,158 shares worth $83M.
  • Shufro Rose & Co added most to ALPS Smith Core Plus Bond ETF in Q1 2025, an estimated $69.3M increase.
  • Shufro Rose & Co's biggest Q1 2025 reduction was iShares iBonds Dec 2027 Term Corporate ETF, cutting an estimated $81.7M.
  • Shufro Rose & Co fully exited iShares iBonds Dec 2026 Term Treasury ETF in Q1 2025, selling an estimated $738K.
  • Shufro Rose & Co's ten largest holdings make up 42% of its $1.27B portfolio in Q1 2025.
  • Shufro Rose & Co opened 24 new positions and closed 8 in Q1 2025.
  • Shufro Rose & Co's portfolio value fell 2.1% quarter-over-quarter to $1.27B.

Based on Shufro Rose & Co's 13F filing for Q1 2025, filed 8 May 2025.